Annual FCF:
$475.42M+$423.77M(+820.51%)Summary
- As of today, BMRN annual free cash flow is $475.42 million, with the most recent change of +$423.77 million (+820.51%) on December 31, 2024.
- During the last 3 years, BMRN annual free cash flow has risen by +$290.11 million (+156.55%).
- BMRN annual free cash flow is now at all-time high.
Performance
BMRN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$167.90M+$10.28M(+6.52%)Summary
- As of today, BMRN quarterly free cash flow is $167.90 million, with the most recent change of +$10.28 million (+6.52%) on June 30, 2025.
- Over the past year, BMRN quarterly free cash flow has increased by +$70.98 million (+73.23%).
- BMRN quarterly free cash flow is now -16.18% below its all-time high of $200.31 million, reached on September 30, 2024.
Performance
BMRN Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$691.16M+$70.98M(+11.45%)Summary
- As of today, BMRN TTM free cash flow is $691.16 million, with the most recent change of +$70.98 million (+11.45%) on June 30, 2025.
- Over the past year, BMRN TTM free cash flow has increased by +$478.36 million (+224.79%).
- BMRN TTM free cash flow is now at all-time high.
Performance
BMRN TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BMRN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +820.5% | +73.2% | +224.8% |
| 3Y3 Years | +156.6% | +495.6% | +10000.0% |
| 5Y5 Years | +512.9% | +3021.1% | +10000.0% |
BMRN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +971.7% | -16.2% | +270.1% | at high | +3074.8% |
| 5Y | 5-Year | at high | +512.9% | -16.2% | +270.1% | at high | +1425.2% |
| All-Time | All-Time | at high | +205.8% | -16.2% | +177.5% | at high | +236.2% |
BMRN Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $167.90M(+6.5%) | $691.16M(+11.4%) |
| Mar 2025 | - | $157.63M(-4.7%) | $620.18M(+30.4%) |
| Dec 2024 | $475.42M(+820.5%) | $165.33M(-17.5%) | $475.42M(+58.0%) |
| Sep 2024 | - | $200.31M(+106.7%) | $300.88M(+41.4%) |
| Jun 2024 | - | $96.92M(+653.3%) | $212.80M(+30.4%) |
| Mar 2024 | - | $12.87M(+239.7%) | $163.21M(+216.0%) |
| Dec 2023 | $51.65M(+16.4%) | -$9.21M(-108.2%) | $51.65M(+65.1%) |
| Sep 2023 | - | $112.23M(+137.1%) | $31.29M(-23.5%) |
| Jun 2023 | - | $47.33M(+148.0%) | $40.91M(+87.9%) |
| Mar 2023 | - | -$98.70M(-233.7%) | $21.77M(-50.9%) |
| Dec 2022 | $44.36M(-76.1%) | -$29.57M(-124.3%) | $44.36M(+8.8%) |
| Sep 2022 | - | $121.85M(+332.2%) | $40.76M(+1027.5%) |
| Jun 2022 | - | $28.19M(+137.0%) | -$4.39M(-118.3%) |
| Mar 2022 | - | -$76.11M(-129.4%) | $23.95M(-87.1%) |
| Dec 2021 | $185.31M(+455.3%) | -$33.18M(-143.3%) | $185.31M(+12.1%) |
| Sep 2021 | - | $76.70M(+35.7%) | $165.24M(+6.9%) |
| Jun 2021 | - | $56.53M(-33.7%) | $154.59M(+67.5%) |
| Mar 2021 | - | $85.26M(+260.1%) | $92.31M(+277.0%) |
| Dec 2020 | -$52.15M(+54.7%) | -$53.25M(-180.6%) | -$52.15M(-2068.6%) |
| Sep 2020 | - | $66.05M(+1249.1%) | -$2.40M(+92.7%) |
| Jun 2020 | - | -$5.75M(+90.3%) | -$32.93M(+60.9%) |
| Mar 2020 | - | -$59.21M(-1592.2%) | -$84.15M(+22.5%) |
| Dec 2019 | -$115.14M(+7.4%) | -$3.50M(-109.8%) | -$108.57M(-11.0%) |
| Sep 2019 | - | $35.53M(+162.4%) | -$97.77M(+28.1%) |
| Jun 2019 | - | -$56.97M(+31.9%) | -$135.96M(-0.4%) |
| Mar 2019 | - | -$83.62M(-1246.3%) | -$135.36M(-8.8%) |
| Dec 2018 | -$124.41M(+40.2%) | $7.29M(+374.4%) | -$124.41M(+20.7%) |
| Sep 2018 | - | -$2.66M(+95.3%) | -$156.98M(+1.0%) |
| Jun 2018 | - | -$56.38M(+22.4%) | -$158.51M(-20.9%) |
| Mar 2018 | - | -$72.67M(-187.5%) | -$131.12M(+37.0%) |
| Dec 2017 | -$207.98M(+44.7%) | -$25.28M(-503.2%) | -$207.98M(+11.3%) |
| Sep 2017 | - | -$4.19M(+85.5%) | -$234.48M(+12.1%) |
| Jun 2017 | - | -$28.98M(+80.6%) | -$266.76M(+13.7%) |
| Mar 2017 | - | -$149.53M(-188.8%) | -$309.09M(+17.8%) |
| Dec 2016 | -$376.22M(+16.3%) | -$51.78M(-42.0%) | -$376.22M(+24.2%) |
| Sep 2016 | - | -$36.46M(+48.9%) | -$496.44M(+2.2%) |
| Jun 2016 | - | -$71.31M(+67.1%) | -$507.38M(-4.8%) |
| Mar 2016 | - | -$216.66M(-26.0%) | -$484.36M(-7.8%) |
| Dec 2015 | -$449.50M(-132.8%) | -$172.01M(-262.8%) | -$449.50M(-34.8%) |
| Sep 2015 | - | -$47.41M(+1.8%) | -$333.48M(-4.2%) |
| Jun 2015 | - | -$48.28M(+73.4%) | -$320.02M(+1.2%) |
| Mar 2015 | - | -$181.81M(-224.8%) | -$323.80M(-67.7%) |
| Dec 2014 | -$193.05M(-54.7%) | -$55.98M(-64.9%) | -$193.05M(-8.4%) |
| Sep 2014 | - | -$33.95M(+34.8%) | -$178.04M(-6.7%) |
| Jun 2014 | - | -$52.06M(-2.0%) | -$166.79M(-26.4%) |
| Mar 2014 | - | -$51.05M(-24.6%) | -$131.95M(-5.8%) |
| Dec 2013 | -$124.76M(-362.7%) | -$40.98M(-80.6%) | -$124.76M(-45.6%) |
| Sep 2013 | - | -$22.69M(-31.7%) | -$85.69M(-34.3%) |
| Jun 2013 | - | -$17.23M(+60.7%) | -$63.79M(-11.0%) |
| Mar 2013 | - | -$43.85M(-2197.3%) | -$57.47M(-113.1%) |
| Dec 2012 | -$26.96M(+80.1%) | -$1.91M(-138.9%) | -$26.96M(+76.5%) |
| Sep 2012 | - | -$799.00K(+92.7%) | -$114.91M(+28.9%) |
| Jun 2012 | - | -$10.90M(+18.3%) | -$161.64M(-16.2%) |
| Mar 2012 | - | -$13.35M(+85.1%) | -$139.08M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$135.47M(-341.0%) | -$89.86M(-89.1%) | -$135.47M(-87.8%) |
| Sep 2011 | - | -$47.53M(-507.7%) | -$72.13M(-189.4%) |
| Jun 2011 | - | $11.66M(+219.7%) | -$24.92M(+15.8%) |
| Mar 2011 | - | -$9.74M(+63.3%) | -$29.60M(+3.6%) |
| Dec 2010 | -$30.71M(-1384.5%) | -$26.52M(-8320.0%) | -$30.71M(-318.1%) |
| Sep 2010 | - | -$315.00K(-104.5%) | -$7.35M(-62.7%) |
| Jun 2010 | - | $6.98M(+164.3%) | -$4.52M(+68.2%) |
| Mar 2010 | - | -$10.86M(-244.2%) | -$14.21M(-586.8%) |
| Dec 2009 | -$2.07M(+96.8%) | -$3.15M(-225.4%) | -$2.07M(+69.9%) |
| Sep 2009 | - | $2.52M(+192.7%) | -$6.87M(+65.0%) |
| Jun 2009 | - | -$2.71M(-311.4%) | -$19.61M(+11.5%) |
| Mar 2009 | - | $1.28M(+116.1%) | -$22.15M(+66.2%) |
| Dec 2008 | -$65.54M(-15.2%) | -$7.96M(+22.2%) | -$65.54M(-0.1%) |
| Sep 2008 | - | -$10.23M(-94.8%) | -$65.46M(+7.3%) |
| Jun 2008 | - | -$5.25M(+87.5%) | -$70.61M(+6.7%) |
| Mar 2008 | - | -$42.11M(-434.9%) | -$75.66M(-32.9%) |
| Dec 2007 | -$56.91M(+23.8%) | -$7.87M(+48.8%) | -$56.91M(+9.6%) |
| Sep 2007 | - | -$15.38M(-49.4%) | -$62.98M(-0.6%) |
| Jun 2007 | - | -$10.29M(+55.9%) | -$62.62M(+19.5%) |
| Mar 2007 | - | -$23.36M(-67.5%) | -$77.79M(-4.2%) |
| Dec 2006 | -$74.67M(-13.8%) | -$13.95M(+7.1%) | -$74.67M(+7.6%) |
| Sep 2006 | - | -$15.02M(+41.0%) | -$80.81M(+8.6%) |
| Jun 2006 | - | -$25.46M(-25.8%) | -$88.39M(-32.1%) |
| Mar 2006 | - | -$20.24M(-0.8%) | -$66.90M(-1.9%) |
| Dec 2005 | -$65.64M(+26.4%) | -$20.08M(+11.1%) | -$65.64M(-4.7%) |
| Sep 2005 | - | -$22.59M(-468.1%) | -$62.70M(+11.6%) |
| Jun 2005 | - | -$3.98M(+79.1%) | -$70.93M(+23.7%) |
| Mar 2005 | - | -$18.98M(-10.8%) | -$92.94M(-4.2%) |
| Dec 2004 | -$89.22M(-10.5%) | -$17.14M(+44.4%) | -$89.22M(+17.7%) |
| Sep 2004 | - | -$30.83M(-18.7%) | -$108.40M(-6.2%) |
| Jun 2004 | - | -$25.98M(-70.2%) | -$102.08M(-21.4%) |
| Mar 2004 | - | -$15.26M(+58.0%) | -$84.07M(-4.1%) |
| Dec 2003 | -$80.77M(-38.2%) | -$36.32M(-48.2%) | -$80.77M(-2.1%) |
| Sep 2003 | - | -$24.50M(-207.1%) | -$79.12M(-29.1%) |
| Jun 2003 | - | -$7.98M(+33.3%) | -$61.30M(-2.4%) |
| Mar 2003 | - | -$11.97M(+65.5%) | -$59.84M(-2.4%) |
| Dec 2002 | -$58.46M(-43.0%) | -$34.67M(-419.1%) | -$58.46M(-60.8%) |
| Sep 2002 | - | -$6.68M(-2.4%) | -$36.36M(+13.9%) |
| Jun 2002 | - | -$6.53M(+38.3%) | -$42.24M(-0.9%) |
| Mar 2002 | - | -$10.58M(+15.9%) | -$41.87M(-2.4%) |
| Dec 2001 | -$40.88M(-145.4%) | -$12.57M(-0.1%) | -$40.88M(-24.0%) |
| Sep 2001 | - | -$12.56M(-104.1%) | -$32.97M(-44.9%) |
| Jun 2001 | - | -$6.16M(+35.8%) | -$22.76M(-15.0%) |
| Mar 2001 | - | -$9.58M(-105.4%) | -$19.79M(-18.8%) |
| Dec 2000 | -$16.66M(+55.4%) | -$4.67M(-98.5%) | -$16.66M(+12.6%) |
| Sep 2000 | - | -$2.35M(+26.2%) | -$19.05M(+37.8%) |
| Jun 2000 | - | -$3.19M(+50.6%) | -$30.62M(+13.7%) |
| Mar 2000 | - | -$6.45M(+8.6%) | -$35.46M(+1.2%) |
| Dec 1999 | -$37.38M(-158.8%) | -$7.06M(+49.3%) | -$35.88M(-24.5%) |
| Sep 1999 | - | -$13.92M(-73.3%) | -$28.82M(-93.4%) |
| Jun 1999 | - | -$8.03M(-16.8%) | -$14.91M(-116.8%) |
| Mar 1999 | - | -$6.88M | -$6.88M |
| Dec 1998 | -$14.44M(-346.2%) | - | - |
| Dec 1997 | -$3.24M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual free cash flow?
- What is the all-time high annual free cash flow for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual free cash flow year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly free cash flow year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM free cash flow year-on-year change?
What is BioMarin Pharmaceutical Inc. annual free cash flow?
The current annual free cash flow of BMRN is $475.42M
What is the all-time high annual free cash flow for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual free cash flow is $475.42M
What is BioMarin Pharmaceutical Inc. annual free cash flow year-on-year change?
Over the past year, BMRN annual free cash flow has changed by +$423.77M (+820.51%)
What is BioMarin Pharmaceutical Inc. quarterly free cash flow?
The current quarterly free cash flow of BMRN is $167.90M
What is the all-time high quarterly free cash flow for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly free cash flow is $200.31M
What is BioMarin Pharmaceutical Inc. quarterly free cash flow year-on-year change?
Over the past year, BMRN quarterly free cash flow has changed by +$70.98M (+73.23%)
What is BioMarin Pharmaceutical Inc. TTM free cash flow?
The current TTM free cash flow of BMRN is $691.16M
What is the all-time high TTM free cash flow for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM free cash flow is $691.16M
What is BioMarin Pharmaceutical Inc. TTM free cash flow year-on-year change?
Over the past year, BMRN TTM free cash flow has changed by +$478.36M (+224.79%)